Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

K

KAPA

Kairos Pharma Ltd

0.3500

Aug 10 • 3:59 PM ET -0.0360 (-9.33%)

0.3550

Aftermarket • 6:25 PM ET +0.0050 (1.43%)

Healthcare Biotechnology USA Nano AMEX

Peers: AIM APRE BCDA BIVI GOVX JAGX KPRX CALC CVM NEUP

Scroll to Statements

Index	-
Market Cap	7.49M
Enterprise Value	3.82M
Income	-5.84M
Sales	0.00M
Book/sh	0.25
Cash/sh	0.17
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	4
IPO	Sep 16, 2024

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.41
P/C	2.04
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	10.31
Current Ratio	10.31
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-0.30
EPS next Y	-0.51
EPS next Q	-0.08
EPS this Y	-10.00%
EPS next Y	-53.03%
EPS next 5Y	-22.76%
EPS past 3/5Y	-53.52% -29.30%
Sales past 3/5Y	- -
EPS Y/Y TTM	-17.50%
Sales Y/Y TTM	-
EPS Q/Q	1.01%
Sales Q/Q	-
Earnings	Jun 03
EPS/Sales Surpr.	0.00% -

Insider Own	37.20%
Insider Trans	0.00%
Inst Own	2.81%
Inst Trans	-7.44%
ROA	-85.36%
ROE	-93.84%
ROIC	-109.90%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	7.74%
SMA50	-7.75%
SMA200	-43.62%
Trades

Shs Outstand	21.41M
Shs Float	13.45M
Short Float	1.43%
Short Ratio	0.09
Short Interest	0.19M
52W High	2.11 -83.41%
52W Low	0.27 29.87%
Volatility	11.46% 13.67%
ATR (14)	0.04
RSI (14)	50.59
Beta	1.76
Rel Volume	0.41
Avg Volume	2.16M
Volume	894,231

Perf Week	12.90%
Perf Month	-0.77%
Perf Quarter	-37.50%
Perf Half Y	-43.09%
Perf YTD	-50.70%
Perf Year	-64.43%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	7.00
Prev Close	0.39
Price	0.35
Change %	-9.33%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)